These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21235596)

  • 1. How do we prevent transfusion-associated graft-versus-host disease in children?
    King KE; Ness PM
    Transfusion; 2011 May; 51(5):916-20. PubMed ID: 21235596
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonlethal transfusion associated graft-versus-host disease in a severe combined immunodeficient patient.
    van Royen-Kerkhof A; Wulffraat NM; Kamphuis SS; Brooimans RA; de Weger RA; Tilanus MG; van Leeuwen EF; Rijkers GT
    Bone Marrow Transplant; 2003 Nov; 32(10):1027-30. PubMed ID: 14595391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion-associated graft-versus-host disease in severe combined immunodeficiency.
    Sebnem Kilic S; Kavurt S; Balaban Adim S
    J Investig Allergol Clin Immunol; 2010; 20(2):153-6. PubMed ID: 20461970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing transfusion-associated graft-versus-host disease.
    Smith DM; Kresie LA
    Transfusion; 2007 Jan; 47(1):173-4; author reply 174. PubMed ID: 17207248
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case of graft-versus-host disease following red cell concentrate (MAP-CRC) transfusion].
    Nakamoto T; Nishi S; Shindoh M; Hayashi M; Yukioka H; Fujimori M; Maekawa N
    Masui; 1995 Sep; 44(9):1261-4. PubMed ID: 8523663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion-associated graft-versus-host disease in a renal transplant recipient.
    Adeva Andany M; Martínez W; Arnal F; Yebra T; García Falcón T; Rodríguez Lozano I; Lorenzo D; Alonso A
    Nephrol Dial Transplant; 1994; 9(2):196-8. PubMed ID: 8190340
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe combined immunodeficiency in a Malaysian child.
    Noh LM; Amir HL; Hung LC; Zulkifli I; Nasuruddin BA
    Med J Malaysia; 1997 Mar; 52(1):88-91. PubMed ID: 10968061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force.
    Transfus Med; 1996 Sep; 6(3):261-71. PubMed ID: 8885157
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of inflammation in respiratory impairment during Pneumocystis carinii pneumonia.
    Hahn PY; Limper AH
    Semin Respir Infect; 2003 Mar; 18(1):40-7. PubMed ID: 12652453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells.
    Triulzi D; Duquesnoy R; Nichols L; Clark K; Jukic D; Zeevi A; Meisner D
    Transfusion; 2006 Jun; 46(6):885-8. PubMed ID: 16734803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-transfusion acute graft versus host disease in a 17-year-old girl with a malignant mesenchymal tumor--report of a case.
    Utkan G; Buyukcelik A; Demir O; Sanli H; Pamir A
    Acta Med Austriaca; 2003; 30(5):138-41. PubMed ID: 15055161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indications for irradiated blood components: dose and side effects].
    Eiermann TH
    Beitr Infusionsther; 1993; 31():70-3. PubMed ID: 7693267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acquired immunodeficiency syndrome and respiratory insufficiency: an unexpected evolution].
    Soler Bel J; Tapiz Reula A; Cisneros Antó JL; Gimeno Cobos JL
    Med Clin (Barc); 1988 Feb; 90(5):219. PubMed ID: 3258394
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic serum levels of tacrolimus after topical administration in an infant with severe cutaneous graft-versus-host disease.
    Prot-Labarthe S; Therrien R; Champagne MA; Duval M; Joubert C
    Bone Marrow Transplant; 2007 Aug; 40(3):295-6. PubMed ID: 17549052
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic posttransfusion graft-vs-host disease in a patient with non-Hodgkin's lymphoma].
    García Gala JM; Ramírez Páyer A; Rayón C; Rodríguez Vicente P; Rosón C; Blanco C
    Sangre (Barc); 1993 Dec; 38(6):489-91. PubMed ID: 8171385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Data-driven blood banking practices for neonatal RBC transfusions.
    Strauss RG
    Transfusion; 2000 Dec; 40(12):1528-40. PubMed ID: 11134575
    [No Abstract]   [Full Text] [Related]  

  • 18. Fatal graft-vs.-host reaction following transfusion of allogeneic blood and plasma in infants with combined immunodeficiency disease.
    Park BH; Good RA; Gate J; Burke B
    Transplant Proc; 1974 Dec; 6(4):385-7. PubMed ID: 4155155
    [No Abstract]   [Full Text] [Related]  

  • 19. Transfusion medicine--2003: a comprehensive review, Part II.
    Menitove JE
    Mo Med; 2003; 100(5):530-4; quiz 534-5. PubMed ID: 14601446
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of transfusion-associated graft-vs-host disease.
    Holland PV
    Arch Pathol Lab Med; 1989 Mar; 113(3):285-91. PubMed ID: 2645855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.